A Novel Drug Delivery System for the Human Nasal Epithelium.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advances in Oto-Rhino-Laryngology

• Publication date

  2016-04-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000441877PMID 27116461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells

  2016cited by this paper
• Poly(I:C) induced microRNA-146a regulates epithelial barrier and secretion of proinflammatory cytokines in human nasal epithelial cells.

  2015cited by this paper
• MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions

  2014cited by this paper
• Role of tight junctions in signal transduction: an update

  2014cited by this paper
• [Targeting the brain through the nose. Effects of intranasally administered insulin].

  2013cited by this paper
• Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells

  2013cited by this paper
• Expression of tricellulin in epithelial cells and non-epithelial cells.

  2013cited by this paper
• Creation and biochemical analysis of a broad-specific claudin binder.

  2012cited by this paper
• Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression*

  2012cited by this paper
• Regulation of Tight Junctions in Upper Airway Epithelium

  2012cited by this paper
• Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-α via distinct NF-κB pathways in human nasal epithelial cells.

  2011cited by this paper
• MicroRNA regulation of intestinal epithelial tight junction permeability.

  2011cited by this paper
• MiR-146a in Immunity and Disease

  2011cited by this paper
• A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.

  2010cited by this paper
• PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells.

  2010cited by this paper
• Tight junction proteins and signal transduction pathways in hepatocytes.

  2009cited by this paper
• Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.

  2009cited by this paper
• Protein Kinase C Enhances Tight Junction Barrier Function of Human Nasal Epithelial Cells in Primary Culture by Transcriptional Regulation

  2008cited by this paper
• Induction of claudins in passaged hTERT-transfected human nasal epithelial cells with an extended life span

  2007cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• HLA-DR- and CD11c-positive Dendritic Cells Penetrate beyond Well-developed Epithelial Tight Junctions in Human Nasal Mucosa of Allergic Rhinitis

  2005cited by this paper
• New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Tight junctions and human diseases

  2003cited by this paper
• Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin‐3, a tight junction integral membrane protein

  2000cited by this paper
• Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands

  1999cited by this paper
• Role of tight junctions in establishing and maintaining cell polarity.

  1998cited by this paper
• Breaking through the tight junction barrier

  1993cited by this paper
• Structure, function, and regulation of cellular tight junctions.

  1992cited by this paper

• Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

  2024influential citation
• Target specific tight junction modulators.

  2021cites this paper
• Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways

  2018cites this paper